Over 50 years ago, tuft cells were first identified within the gastrointestinal tract and other organs. More recently, the unique appearance and dynamic behavior of these epithelial cells have attracted considerable attention. Intestinal tuft cells are characterized by a long apical ''tuft'' of microvilli that extends into the gut lumen, consistent with a suspected function in sensing luminal components. Under homeostatic conditions, tuft cells are rare, but they expand dramatically during inflammation and repair, suggesting a role in regeneration and/or disease. However, exactly what tuft cells sense and how they contribute to homeostasis and disease have been longstanding questions. Recent studies established a close connection between tuft cells and type 2 innate lymphoid cells (ILC2s), with tuft cells acting as a primary source of IL-25, inducing ILC2s to secrete IL-13, leading to expansion of tuft and goblet cells and contributing to the clearance of helminths (Gieseck et al., 2018) . In this issue of Cell, Schneider et al. (2018) find that the protozoan Tritrichomonas activates the tuft cell-ILC2 circuit and that this circuit can lead to an expansion of secretory cells and lengthening of the small intestine that helps clear infection, maintain metabolic homeostasis, and prevent subsequent colonization through ''concomitant immunity.'' Interestingly, ILC2-specific deletion of a negative regulator of IL-17 signaling, A20, mimics Tritrichomonas-induced circuit activation, which is shown to be mediated by luminal succinate sensed by tuft cells. Therefore, this paper unravels the tripartite interaction between diet, metabolites produced by pathosymbionts, and intestinal remodeling governed by the tuft-ILC2 circuit.
Although only relatively recently discovered, the roles of ILC2s are diverse. ILC2s are involved in type 2 immune diseases such as allergic/atopic reactions and parasitic infections. While the key IL-25-IL-17RB signaling axis appears to be central to the activation of ILC2s during helminth infection, ILC2s express a variety of receptors and interact with many cell types; thus, their contribution to mucosal immunity is likely complex. For example, the alarmin IL-33 and emerging neuroimmune modulators such as neuromedin U (NMU) and noradrenaline may play a role in ILC2 function, given the abundant expression of their receptors in ILC2s (Klose et al., 2017; Moriyama et al., 2018) . ILC2s also contribute to the progression of gastric and biliary cancers, possibly related to their secretion of Wnt5a or IL-33 (Hayakawa et al., 2015; Nakagawa et al., 2017 (Westphalen et al., 2014) . Gastrointestinal tuft cells are also a major epithelial source of acetylcholine and prostaglandin E2, both of which can activate proliferation of gut progenitors. In contrast, the current study highlights an immune signaling function of these specialized cells, demonstrating that tuft cells release IL-25 and activate IL-4Ra-expressing intestinal progenitors via ILC2s, ultimately resulting in the goblet and tuft cell hyperplasia that accompanies the ''weep-and sweep'' response to worms and lengthening of the small intestine (Figure 1 ).
This work demonstrates the central role of the tuft-ILC2 circuit in orchestrating the intestinal response to pathosymbionts; however, the precise cell types that respond to IL-13, resulting in intestinal lengthening, remain to be determined.
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+ cells appear to contribute to crypt fission in response to these signals, but further studies are needed to demonstrate that they represent the critical IL-13 target. However, given that IL-4Ra and IL-13Ra1 are broadly expressed, secretory progenitors such as Dll1 + or Prox1 + cells may also be responsible. Notably, the IL-25/IL-13 response does not lead to intestinal hypertrophy with stem cell expansion but only intestinal lengthening, suggesting a unique effect on stem/progenitor cells. Schneider et al. show that tuft cells mediate the response to pathosymbionts by sensing the short-chain fatty acid (SCFA) succinate via their succinate receptor GPR91 (Figure 1) , strengthening the general role of tuft cells as sensory cells (Lei et al., 2018; Schneider et al., 2018) . Similar effects were caused by inulin, a fermentable fiber that can be metabolized by Tritrichomonas, as well as colonic bacteria, leading to increased fecal concentrations of SCFA. This activation occurs at the time of weaning, with the change from milk to a fiber-containing diet, confirming the importance of microbial-generated SCFAs in the regulation of intestinal homeostasis. Tritrichomonas is a pathosymbiont rather than a true commensal, but normal gut bacteria have also been linked to SCFA production and thus may also be able to activate this pathway.
In addition to helminths and protists, gastrointestinal infection by bacteria such as Helicobacter hepaticus, H. felis, or Bacteroides fragilis leads to tuft cell expansion. However, in these cases, it is unknown whether tuft cell expansion is the result of the type 2 immune circuit or whether such tuft cell expansion contributes to protection from pathogens. Interestingly, tuft cell expansion mediated by type 2 cytokines actually promotes Norovirus infection, as the murine Norovirus receptor is expressed specifically in tuft cells (Wilen et al., 2018) . Tuft cells also increase in response to other inflammatory or procarcinogenic stimuli, such as IL-1b, bile acids, or nitrosamine in models of gastroesophageal metaplasia/ dysplasia, and promote carcinogenesis via acetylcholine-CHRM3 signaling . It remains uncertain whether these other types of injury are directly sensed by tuft cells or their progenitors. The contribution by tuft cells to epithelial injury may indeed vary, depending on organs and conditions, and thus, the broad landscape of tuft cell function in disease remains to be defined. Nevertheless, the work by Schneider et al. elucidates the essential role of tuft cells in gut homeostasis as a luminal sensor and upstream modulator of ILCs and intestinal progenitors, constituting a major advance in our understanding of intestinal biology. The cytoplasm is a highly crowded and complex environment, and the regulation of its physical properties has only recently begun to be revealed. In this issue of Cell, Delarue et al. demonstrate that the control of ribosome concentration through mTORC1 sets limits on the diffusion of large particles and controls phase separation in eukaryotic cells.
In the 1940s, Francis Crick measured the movement of phagocytosed magnetic particles in chick embryos and concluded that the cytoplasm was not strictly elastic, as had been thought, but rather behaved as a gel (Crick and Hughes, 1950) . Today, we know that the cytoplasm is a highly crowded environment in which at least 20% of the volume is composed of proteins; the viscosity of the cytoplasm has been estimated to be at least several times that of water (Luby-Phelps et al., 1986; van den Berg et al., 2017) . The intracellular density of cells is often assumed to be tightly regulated to ensure proper biosynthetic coordination and molecular mobility, but the extent to which and how this regulation occurs have remained unclear. Proteins that have a stronger propensity to self-associate than to interact with the solvent can undergo a phase transition-where a large number of interacting proteins coalesce into a condensed liquid phase that is separate from the surrounding bulk liquid solvent-and have recently emerged as central players in several biological processes (Boeynaems et al., 2018) . Whether such phase transitions are regulated by cells remains speculative, but it is clear that macromolecular crowding plays a key role in promoting the demixing of molecules in solution. In this issue of Cell, Delarue et al. (2018) introduce a powerful tool for probing cytoplasmic properties at length scales previously challenging to study across a broad range of organisms, revealing that ribosome concentration regulates the diffusion of large particles and controls phase separation.
Common methods for measuring diffusive behavior in living cells generally involve tracking the movement of fluorescently labeled particles. These techniques are limited by the fixed or undefined sizes of tracer particles and the number of emission cycles that the fluorophore can undergo before photobleaching, and changes in the motion of native structures may be due to direct regulation rather than the biophysical properties of the cell. To address these issues, Delarue et al. developed genetically encoded
